nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE7A—renal system—uterine cancer	0.0227	0.0488	CbGeAlD
Ketotifen—PDE8A—myometrium—uterine cancer	0.0195	0.042	CbGeAlD
Ketotifen—PDE7A—female reproductive system—uterine cancer	0.0182	0.0391	CbGeAlD
Ketotifen—PDE8B—uterine cervix—uterine cancer	0.0169	0.0363	CbGeAlD
Ketotifen—PDE8A—uterine cervix—uterine cancer	0.0152	0.0327	CbGeAlD
Ketotifen—PDE8A—smooth muscle tissue—uterine cancer	0.0147	0.0318	CbGeAlD
Ketotifen—PDE8A—decidua—uterine cancer	0.0145	0.0311	CbGeAlD
Ketotifen—PDE8B—uterus—uterine cancer	0.0141	0.0303	CbGeAlD
Ketotifen—PDE8A—endometrium—uterine cancer	0.0137	0.0296	CbGeAlD
Ketotifen—PDE8A—mammalian vulva—uterine cancer	0.0133	0.0286	CbGeAlD
Ketotifen—PDE8A—uterus—uterine cancer	0.0126	0.0272	CbGeAlD
Ketotifen—PDE8B—female reproductive system—uterine cancer	0.0126	0.0272	CbGeAlD
Ketotifen—PGD—myometrium—uterine cancer	0.0118	0.0255	CbGeAlD
Ketotifen—PDE4A—decidua—uterine cancer	0.0116	0.025	CbGeAlD
Ketotifen—PDE8B—vagina—uterine cancer	0.0114	0.0246	CbGeAlD
Ketotifen—Hepatic enzyme increased—Progesterone—uterine cancer	0.011	0.0222	CcSEcCtD
Ketotifen—PDE8A—female gonad—uterine cancer	0.0103	0.0223	CbGeAlD
Ketotifen—PDE8A—vagina—uterine cancer	0.0103	0.0221	CbGeAlD
Ketotifen—Cystitis noninfective—Progesterone—uterine cancer	0.0101	0.0205	CcSEcCtD
Ketotifen—Cystitis—Progesterone—uterine cancer	0.01	0.0203	CcSEcCtD
Ketotifen—Bladder pain—Progesterone—uterine cancer	0.00938	0.019	CcSEcCtD
Ketotifen—PDE4D—female gonad—uterine cancer	0.00937	0.0202	CbGeAlD
Ketotifen—PDE7B—lymph node—uterine cancer	0.00928	0.02	CbGeAlD
Ketotifen—PGD—uterine cervix—uterine cancer	0.00922	0.0199	CbGeAlD
Ketotifen—Cystitis noninfective—Medroxyprogesterone Acetate—uterine cancer	0.00918	0.0186	CcSEcCtD
Ketotifen—Cystitis—Medroxyprogesterone Acetate—uterine cancer	0.00908	0.0184	CcSEcCtD
Ketotifen—PGD—smooth muscle tissue—uterine cancer	0.00896	0.0193	CbGeAlD
Ketotifen—PGD—decidua—uterine cancer	0.00878	0.0189	CbGeAlD
Ketotifen—Sleep disorder—Progesterone—uterine cancer	0.0087	0.0176	CcSEcCtD
Ketotifen—PGD—renal system—uterine cancer	0.00863	0.0186	CbGeAlD
Ketotifen—Bladder pain—Medroxyprogesterone Acetate—uterine cancer	0.0085	0.0172	CcSEcCtD
Ketotifen—PGD—endometrium—uterine cancer	0.00834	0.018	CbGeAlD
Ketotifen—PDE4A—female gonad—uterine cancer	0.00829	0.0179	CbGeAlD
Ketotifen—PGD—mammalian vulva—uterine cancer	0.00807	0.0174	CbGeAlD
Ketotifen—Increased appetite—Progesterone—uterine cancer	0.00802	0.0162	CcSEcCtD
Ketotifen—PGD—uterus—uterine cancer	0.00768	0.0166	CbGeAlD
Ketotifen—PDE8B—lymph node—uterine cancer	0.00739	0.0159	CbGeAlD
Ketotifen—Haematochezia—Epirubicin—uterine cancer	0.00739	0.015	CcSEcCtD
Ketotifen—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00726	0.0147	CcSEcCtD
Ketotifen—PDE4B—uterine cervix—uterine cancer	0.00725	0.0156	CbGeAlD
Ketotifen—Irritability—Progesterone—uterine cancer	0.00719	0.0146	CcSEcCtD
Ketotifen—Infection—Carboplatin—uterine cancer	0.007	0.0142	CcSEcCtD
Ketotifen—PDE4B—decidua—uterine cancer	0.00691	0.0149	CbGeAlD
Ketotifen—PGD—female reproductive system—uterine cancer	0.00691	0.0149	CbGeAlD
Ketotifen—Haematochezia—Doxorubicin—uterine cancer	0.00684	0.0138	CcSEcCtD
Ketotifen—PDE8A—lymph node—uterine cancer	0.00665	0.0143	CbGeAlD
Ketotifen—Tingling sensation—Etoposide—uterine cancer	0.0066	0.0134	CcSEcCtD
Ketotifen—PDE4B—endometrium—uterine cancer	0.00656	0.0141	CbGeAlD
Ketotifen—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00651	0.0132	CcSEcCtD
Ketotifen—PDE4B—mammalian vulva—uterine cancer	0.00635	0.0137	CbGeAlD
Ketotifen—PGD—female gonad—uterine cancer	0.00629	0.0135	CbGeAlD
Ketotifen—PGD—vagina—uterine cancer	0.00625	0.0135	CbGeAlD
Ketotifen—Pain—Carboplatin—uterine cancer	0.00603	0.0122	CcSEcCtD
Ketotifen—PDE4D—lymph node—uterine cancer	0.00603	0.013	CbGeAlD
Ketotifen—Weight increased—Progesterone—uterine cancer	0.00592	0.012	CcSEcCtD
Ketotifen—Drowsiness—Progesterone—uterine cancer	0.0058	0.0118	CcSEcCtD
Ketotifen—Body temperature increased—Carboplatin—uterine cancer	0.00557	0.0113	CcSEcCtD
Ketotifen—PDE4B—female reproductive system—uterine cancer	0.00543	0.0117	CbGeAlD
Ketotifen—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00537	0.0109	CcSEcCtD
Ketotifen—HRH1—myometrium—uterine cancer	0.00536	0.0115	CbGeAlD
Ketotifen—PDE4A—lymph node—uterine cancer	0.00533	0.0115	CbGeAlD
Ketotifen—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00526	0.0107	CcSEcCtD
Ketotifen—Hepatitis—Progesterone—uterine cancer	0.00521	0.0106	CcSEcCtD
Ketotifen—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00496	0.01	CcSEcCtD
Ketotifen—PDE4B—female gonad—uterine cancer	0.00495	0.0107	CbGeAlD
Ketotifen—Erythema multiforme—Progesterone—uterine cancer	0.00493	0.00998	CcSEcCtD
Ketotifen—PDE4B—vagina—uterine cancer	0.00492	0.0106	CbGeAlD
Ketotifen—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00472	0.00956	CcSEcCtD
Ketotifen—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00446	0.00904	CcSEcCtD
Ketotifen—Tension—Progesterone—uterine cancer	0.00445	0.00901	CcSEcCtD
Ketotifen—Nervousness—Progesterone—uterine cancer	0.00441	0.00892	CcSEcCtD
Ketotifen—HRH1—epithelium—uterine cancer	0.00421	0.00906	CbGeAlD
Ketotifen—HRH1—uterine cervix—uterine cancer	0.00417	0.00898	CbGeAlD
Ketotifen—Syncope—Progesterone—uterine cancer	0.00407	0.00824	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00407	0.00824	CcSEcCtD
Ketotifen—HRH1—smooth muscle tissue—uterine cancer	0.00405	0.00873	CbGeAlD
Ketotifen—PGD—lymph node—uterine cancer	0.00404	0.0087	CbGeAlD
Ketotifen—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00403	0.00817	CcSEcCtD
Ketotifen—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00399	0.00809	CcSEcCtD
Ketotifen—Loss of consciousness—Progesterone—uterine cancer	0.00399	0.00807	CcSEcCtD
Ketotifen—HRH1—decidua—uterine cancer	0.00397	0.00856	CbGeAlD
Ketotifen—Hypertension—Progesterone—uterine cancer	0.00392	0.00793	CcSEcCtD
Ketotifen—Dry mouth—Progesterone—uterine cancer	0.00378	0.00765	CcSEcCtD
Ketotifen—HRH1—endometrium—uterine cancer	0.00377	0.00813	CbGeAlD
Ketotifen—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.00747	CcSEcCtD
Ketotifen—Hepatitis—Dactinomycin—uterine cancer	0.00368	0.00746	CcSEcCtD
Ketotifen—Infection—Progesterone—uterine cancer	0.00368	0.00745	CcSEcCtD
Ketotifen—Stinging—Epirubicin—uterine cancer	0.00367	0.00744	CcSEcCtD
Ketotifen—HRH1—mammalian vulva—uterine cancer	0.00365	0.00786	CbGeAlD
Ketotifen—Shock—Progesterone—uterine cancer	0.00364	0.00738	CcSEcCtD
Ketotifen—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00361	0.00732	CcSEcCtD
Ketotifen—Erythema multiforme—Dactinomycin—uterine cancer	0.00348	0.00705	CcSEcCtD
Ketotifen—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00342	0.00693	CcSEcCtD
Ketotifen—Stinging—Doxorubicin—uterine cancer	0.0034	0.00688	CcSEcCtD
Ketotifen—Insomnia—Progesterone—uterine cancer	0.00335	0.00678	CcSEcCtD
Ketotifen—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.00675	CcSEcCtD
Ketotifen—Paraesthesia—Progesterone—uterine cancer	0.00332	0.00673	CcSEcCtD
Ketotifen—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.00668	CcSEcCtD
Ketotifen—Somnolence—Progesterone—uterine cancer	0.00329	0.00667	CcSEcCtD
Ketotifen—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00665	CcSEcCtD
Ketotifen—PDE4B—lymph node—uterine cancer	0.00318	0.00685	CbGeAlD
Ketotifen—Pain—Progesterone—uterine cancer	0.00317	0.00641	CcSEcCtD
Ketotifen—HRH1—female reproductive system—uterine cancer	0.00312	0.00673	CbGeAlD
Ketotifen—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00303	0.00614	CcSEcCtD
Ketotifen—Gastrointestinal pain—Progesterone—uterine cancer	0.00303	0.00613	CcSEcCtD
Ketotifen—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.0061	CcSEcCtD
Ketotifen—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.00604	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00294	0.00596	CcSEcCtD
Ketotifen—Urticaria—Progesterone—uterine cancer	0.00294	0.00596	CcSEcCtD
Ketotifen—Abdominal pain—Progesterone—uterine cancer	0.00293	0.00593	CcSEcCtD
Ketotifen—Body temperature increased—Progesterone—uterine cancer	0.00293	0.00593	CcSEcCtD
Ketotifen—Cystitis noninfective—Epirubicin—uterine cancer	0.00291	0.00589	CcSEcCtD
Ketotifen—Cystitis—Epirubicin—uterine cancer	0.00287	0.00582	CcSEcCtD
Ketotifen—HRH1—female gonad—uterine cancer	0.00284	0.00613	CbGeAlD
Ketotifen—HRH1—vagina—uterine cancer	0.00283	0.00609	CbGeAlD
Ketotifen—Dry eye—Epirubicin—uterine cancer	0.00275	0.00557	CcSEcCtD
Ketotifen—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00556	CcSEcCtD
Ketotifen—Bladder pain—Epirubicin—uterine cancer	0.00269	0.00545	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—uterine cancer	0.00269	0.00545	CcSEcCtD
Ketotifen—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.0054	CcSEcCtD
Ketotifen—Cystitis—Doxorubicin—uterine cancer	0.00266	0.00538	CcSEcCtD
Ketotifen—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00537	CcSEcCtD
Ketotifen—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00537	CcSEcCtD
Ketotifen—Pruritus—Progesterone—uterine cancer	0.00262	0.0053	CcSEcCtD
Ketotifen—Infection—Dactinomycin—uterine cancer	0.0026	0.00526	CcSEcCtD
Ketotifen—Thrombocytopenia—Dactinomycin—uterine cancer	0.00256	0.00519	CcSEcCtD
Ketotifen—Dry eye—Doxorubicin—uterine cancer	0.00254	0.00515	CcSEcCtD
Ketotifen—Diarrhoea—Progesterone—uterine cancer	0.00253	0.00513	CcSEcCtD
Ketotifen—Erythema multiforme—Etoposide—uterine cancer	0.00252	0.0051	CcSEcCtD
Ketotifen—Bladder pain—Doxorubicin—uterine cancer	0.00249	0.00504	CcSEcCtD
Ketotifen—Dizziness—Progesterone—uterine cancer	0.00245	0.00496	CcSEcCtD
Ketotifen—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00481	CcSEcCtD
Ketotifen—Vomiting—Progesterone—uterine cancer	0.00235	0.00477	CcSEcCtD
Ketotifen—Rash—Progesterone—uterine cancer	0.00233	0.00473	CcSEcCtD
Ketotifen—Dermatitis—Progesterone—uterine cancer	0.00233	0.00472	CcSEcCtD
Ketotifen—Headache—Progesterone—uterine cancer	0.00232	0.0047	CcSEcCtD
Ketotifen—Increased appetite—Epirubicin—uterine cancer	0.0023	0.00466	CcSEcCtD
Ketotifen—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00465	CcSEcCtD
Ketotifen—Pain—Dactinomycin—uterine cancer	0.00224	0.00453	CcSEcCtD
Ketotifen—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00449	CcSEcCtD
Ketotifen—Nausea—Progesterone—uterine cancer	0.0022	0.00445	CcSEcCtD
Ketotifen—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00214	0.00433	CcSEcCtD
Ketotifen—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00432	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—uterine cancer	0.00213	0.00431	CcSEcCtD
Ketotifen—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00428	CcSEcCtD
Ketotifen—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00428	CcSEcCtD
Ketotifen—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00426	CcSEcCtD
Ketotifen—Abdominal pain—Dactinomycin—uterine cancer	0.00207	0.00419	CcSEcCtD
Ketotifen—Body temperature increased—Dactinomycin—uterine cancer	0.00207	0.00419	CcSEcCtD
Ketotifen—Loss of consciousness—Etoposide—uterine cancer	0.00204	0.00413	CcSEcCtD
Ketotifen—Hypertension—Etoposide—uterine cancer	0.002	0.00406	CcSEcCtD
Ketotifen—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00404	CcSEcCtD
Ketotifen—Infection—Etoposide—uterine cancer	0.00188	0.00381	CcSEcCtD
Ketotifen—Thrombocytopenia—Etoposide—uterine cancer	0.00185	0.00376	CcSEcCtD
Ketotifen—HRH1—lymph node—uterine cancer	0.00183	0.00394	CbGeAlD
Ketotifen—Diarrhoea—Dactinomycin—uterine cancer	0.00179	0.00363	CcSEcCtD
Ketotifen—Paraesthesia—Etoposide—uterine cancer	0.0017	0.00344	CcSEcCtD
Ketotifen—Weight increased—Epirubicin—uterine cancer	0.0017	0.00344	CcSEcCtD
Ketotifen—Somnolence—Etoposide—uterine cancer	0.00168	0.00341	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—uterine cancer	0.00166	0.00337	CcSEcCtD
Ketotifen—Vomiting—Dactinomycin—uterine cancer	0.00166	0.00337	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00165	0.00334	CcSEcCtD
Ketotifen—Rash—Dactinomycin—uterine cancer	0.00165	0.00334	CcSEcCtD
Ketotifen—Pain—Etoposide—uterine cancer	0.00162	0.00328	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—uterine cancer	0.00157	0.00318	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—uterine cancer	0.00157	0.00318	CcSEcCtD
Ketotifen—Nausea—Dactinomycin—uterine cancer	0.00155	0.00315	CcSEcCtD
Ketotifen—Gastrointestinal pain—Etoposide—uterine cancer	0.00155	0.00314	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—uterine cancer	0.00154	0.00312	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00153	0.00309	CcSEcCtD
Ketotifen—Urticaria—Etoposide—uterine cancer	0.0015	0.00305	CcSEcCtD
Ketotifen—Abdominal pain—Etoposide—uterine cancer	0.0015	0.00303	CcSEcCtD
Ketotifen—Body temperature increased—Etoposide—uterine cancer	0.0015	0.00303	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—uterine cancer	0.00149	0.00303	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—uterine cancer	0.00145	0.00294	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—uterine cancer	0.00141	0.00286	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—uterine cancer	0.00138	0.0028	CcSEcCtD
Ketotifen—Pruritus—Etoposide—uterine cancer	0.00134	0.00271	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—uterine cancer	0.00131	0.00265	CcSEcCtD
Ketotifen—Diarrhoea—Etoposide—uterine cancer	0.0013	0.00262	CcSEcCtD
Ketotifen—Tension—Epirubicin—uterine cancer	0.00128	0.00259	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—uterine cancer	0.00126	0.00256	CcSEcCtD
Ketotifen—Dizziness—Etoposide—uterine cancer	0.00125	0.00254	CcSEcCtD
Ketotifen—Vomiting—Etoposide—uterine cancer	0.0012	0.00244	CcSEcCtD
Ketotifen—Rash—Etoposide—uterine cancer	0.00119	0.00242	CcSEcCtD
Ketotifen—Dermatitis—Etoposide—uterine cancer	0.00119	0.00242	CcSEcCtD
Ketotifen—Headache—Etoposide—uterine cancer	0.00119	0.0024	CcSEcCtD
Ketotifen—Tension—Doxorubicin—uterine cancer	0.00118	0.00239	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—uterine cancer	0.00117	0.00237	CcSEcCtD
Ketotifen—Syncope—Epirubicin—uterine cancer	0.00117	0.00236	CcSEcCtD
Ketotifen—Loss of consciousness—Epirubicin—uterine cancer	0.00114	0.00232	CcSEcCtD
Ketotifen—Nausea—Etoposide—uterine cancer	0.00112	0.00228	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—uterine cancer	0.00112	0.00227	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—uterine cancer	0.00108	0.00219	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—uterine cancer	0.00108	0.00219	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—uterine cancer	0.00106	0.00214	CcSEcCtD
Ketotifen—Infection—Epirubicin—uterine cancer	0.00105	0.00214	CcSEcCtD
Ketotifen—Shock—Epirubicin—uterine cancer	0.00104	0.00212	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—uterine cancer	0.00104	0.00211	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—uterine cancer	0.00104	0.0021	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—uterine cancer	0.001	0.00203	CcSEcCtD
Ketotifen—Infection—Doxorubicin—uterine cancer	0.000976	0.00198	CcSEcCtD
Ketotifen—Shock—Doxorubicin—uterine cancer	0.000966	0.00196	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—uterine cancer	0.000962	0.00195	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—uterine cancer	0.00096	0.00194	CcSEcCtD
Ketotifen—Paraesthesia—Epirubicin—uterine cancer	0.000953	0.00193	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—uterine cancer	0.000944	0.00191	CcSEcCtD
Ketotifen—Pain—Epirubicin—uterine cancer	0.000908	0.00184	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—uterine cancer	0.000888	0.0018	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—uterine cancer	0.000882	0.00179	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—uterine cancer	0.000873	0.00177	CcSEcCtD
Ketotifen—Gastrointestinal pain—Epirubicin—uterine cancer	0.000868	0.00176	CcSEcCtD
Ketotifen—Urticaria—Epirubicin—uterine cancer	0.000843	0.00171	CcSEcCtD
Ketotifen—Pain—Doxorubicin—uterine cancer	0.00084	0.0017	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—uterine cancer	0.000839	0.0017	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—uterine cancer	0.000839	0.0017	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000803	0.00163	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—uterine cancer	0.00078	0.00158	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—uterine cancer	0.000777	0.00157	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—uterine cancer	0.000777	0.00157	CcSEcCtD
Ketotifen—Pruritus—Epirubicin—uterine cancer	0.000751	0.00152	CcSEcCtD
Ketotifen—Diarrhoea—Epirubicin—uterine cancer	0.000726	0.00147	CcSEcCtD
Ketotifen—Dizziness—Epirubicin—uterine cancer	0.000702	0.00142	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—uterine cancer	0.000695	0.00141	CcSEcCtD
Ketotifen—Vomiting—Epirubicin—uterine cancer	0.000675	0.00137	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—uterine cancer	0.000672	0.00136	CcSEcCtD
Ketotifen—Rash—Epirubicin—uterine cancer	0.000669	0.00136	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—uterine cancer	0.000669	0.00135	CcSEcCtD
Ketotifen—Headache—Epirubicin—uterine cancer	0.000665	0.00135	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—uterine cancer	0.00065	0.00132	CcSEcCtD
Ketotifen—Nausea—Epirubicin—uterine cancer	0.000631	0.00128	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—uterine cancer	0.000625	0.00126	CcSEcCtD
Ketotifen—Rash—Doxorubicin—uterine cancer	0.000619	0.00125	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—uterine cancer	0.000619	0.00125	CcSEcCtD
Ketotifen—Headache—Doxorubicin—uterine cancer	0.000615	0.00125	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—uterine cancer	0.000583	0.00118	CcSEcCtD
Ketotifen—PDE7B—Signaling by GPCR—KRAS—uterine cancer	5.64e-05	0.00134	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN2B—uterine cancer	5.64e-05	0.00134	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—FBXW7—uterine cancer	5.52e-05	0.00131	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—STK11—uterine cancer	5.47e-05	0.0013	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IGF1R—uterine cancer	5.47e-05	0.0013	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CXCL8—uterine cancer	5.45e-05	0.0013	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCL2—uterine cancer	5.45e-05	0.0013	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CXCL8—uterine cancer	5.41e-05	0.00129	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CXCL8—uterine cancer	5.41e-05	0.00129	CbGpPWpGaD
Ketotifen—PGD—Disease—CDKN1B—uterine cancer	5.38e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—HRAS—uterine cancer	5.38e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—HRAS—uterine cancer	5.38e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—PIK3CA—uterine cancer	5.3e-05	0.00126	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	5.29e-05	0.00126	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CDKN1B—uterine cancer	5.29e-05	0.00126	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CDKN1B—uterine cancer	5.29e-05	0.00126	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—KRAS—uterine cancer	5.24e-05	0.00125	CbGpPWpGaD
Ketotifen—PDE8B—GPCR downstream signaling—AKT1—uterine cancer	5.23e-05	0.00124	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—AKT1—uterine cancer	5.23e-05	0.00124	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—STK11—uterine cancer	5.21e-05	0.00124	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCL2—uterine cancer	5.19e-05	0.00123	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—PIK3CA—uterine cancer	5.18e-05	0.00123	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SMAD3—uterine cancer	5.15e-05	0.00123	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SOCS3—uterine cancer	5.13e-05	0.00122	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—ERBB2—uterine cancer	5.09e-05	0.00121	CbGpPWpGaD
Ketotifen—PGD—Disease—CTNNB1—uterine cancer	5.08e-05	0.00121	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKR1B10—uterine cancer	5.08e-05	0.00121	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CTNNB1—uterine cancer	4.99e-05	0.00119	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CTNNB1—uterine cancer	4.99e-05	0.00119	CbGpPWpGaD
Ketotifen—PGD—Disease—PTEN—uterine cancer	4.95e-05	0.00118	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CXCL8—uterine cancer	4.95e-05	0.00118	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—FGFR2—uterine cancer	4.91e-05	0.00117	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN2B—uterine cancer	4.91e-05	0.00117	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SOCS3—uterine cancer	4.88e-05	0.00116	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PTEN—uterine cancer	4.87e-05	0.00116	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PTEN—uterine cancer	4.87e-05	0.00116	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CXCL8—uterine cancer	4.82e-05	0.00115	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—STK11—uterine cancer	4.82e-05	0.00115	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—PIK3CA—uterine cancer	4.82e-05	0.00115	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCL2—uterine cancer	4.8e-05	0.00114	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—HRAS—uterine cancer	4.79e-05	0.00114	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IGF1R—uterine cancer	4.76e-05	0.00113	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—AKT1—uterine cancer	4.75e-05	0.00113	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—AKT1—uterine cancer	4.75e-05	0.00113	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CXCL8—uterine cancer	4.74e-05	0.00113	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—ERBB2—uterine cancer	4.73e-05	0.00113	CbGpPWpGaD
Ketotifen—PGD—Disease—EP300—uterine cancer	4.72e-05	0.00112	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CDKN1B—uterine cancer	4.71e-05	0.00112	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN2B—uterine cancer	4.67e-05	0.00111	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—AKT1—uterine cancer	4.66e-05	0.00111	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—EP300—uterine cancer	4.64e-05	0.00111	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—EP300—uterine cancer	4.64e-05	0.00111	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IGF1R—uterine cancer	4.54e-05	0.00108	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	4.53e-05	0.00108	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CXCL8—uterine cancer	4.52e-05	0.00107	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SOCS3—uterine cancer	4.51e-05	0.00107	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CXCL8—uterine cancer	4.49e-05	0.00107	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SMAD3—uterine cancer	4.48e-05	0.00107	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—HRAS—uterine cancer	4.46e-05	0.00106	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CTNNB1—uterine cancer	4.45e-05	0.00106	CbGpPWpGaD
Ketotifen—PGD—Disease—NRAS—uterine cancer	4.42e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—VEGFA—uterine cancer	4.4e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—VEGFA—uterine cancer	4.4e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CDKN1B—uterine cancer	4.38e-05	0.00104	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—NRAS—uterine cancer	4.34e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—NRAS—uterine cancer	4.34e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PTEN—uterine cancer	4.34e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—AKT1—uterine cancer	4.33e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN2B—uterine cancer	4.32e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CXCL8—uterine cancer	4.31e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—FGFR2—uterine cancer	4.27e-05	0.00102	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SMAD3—uterine cancer	4.26e-05	0.00102	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—AKT1—uterine cancer	4.23e-05	0.00101	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RNF43—uterine cancer	4.21e-05	0.001	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—ESR1—uterine cancer	4.2e-05	0.001	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IGF1R—uterine cancer	4.2e-05	0.000999	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	4.18e-05	0.000996	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CXCL8—uterine cancer	4.18e-05	0.000995	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PTEN—uterine cancer	4.15e-05	0.000987	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CTNNB1—uterine cancer	4.14e-05	0.000985	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—EP300—uterine cancer	4.14e-05	0.000985	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CXCL8—uterine cancer	4.1e-05	0.000976	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—FGFR2—uterine cancer	4.07e-05	0.000968	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PTEN—uterine cancer	4.03e-05	0.00096	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCL2—uterine cancer	4.03e-05	0.000959	CbGpPWpGaD
Ketotifen—HRH1—G alpha (q) signalling events—PIK3CA—uterine cancer	4.01e-05	0.000954	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—NRAS—uterine cancer	3.97e-05	0.000945	CbGpPWpGaD
Ketotifen—PGD—Metabolism—EP300—uterine cancer	3.96e-05	0.000942	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SMAD3—uterine cancer	3.95e-05	0.000939	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—AKT1—uterine cancer	3.93e-05	0.000937	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—VEGFA—uterine cancer	3.92e-05	0.000933	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	3.9e-05	0.000929	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—NRAS—uterine cancer	3.87e-05	0.000921	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—EP300—uterine cancer	3.85e-05	0.000916	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—INHBA—uterine cancer	3.85e-05	0.000916	CbGpPWpGaD
Ketotifen—PGD—Disease—KRAS—uterine cancer	3.8e-05	0.000905	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CXCL8—uterine cancer	3.79e-05	0.000903	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—FGFR2—uterine cancer	3.76e-05	0.000896	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—KRAS—uterine cancer	3.74e-05	0.00089	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—KRAS—uterine cancer	3.74e-05	0.00089	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCL2—uterine cancer	3.7e-05	0.00088	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ESR1—uterine cancer	3.66e-05	0.00087	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—VEGFA—uterine cancer	3.64e-05	0.000867	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—NRAS—uterine cancer	3.6e-05	0.000857	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	3.58e-05	0.000853	CbGpPWpGaD
Ketotifen—PGD—Disease—PIK3CA—uterine cancer	3.49e-05	0.000832	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ESR1—uterine cancer	3.48e-05	0.000828	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKR1C1—uterine cancer	3.46e-05	0.000824	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—PIK3CA—uterine cancer	3.46e-05	0.000823	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—NRAS—uterine cancer	3.46e-05	0.000823	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PIK3CA—uterine cancer	3.43e-05	0.000817	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PIK3CA—uterine cancer	3.43e-05	0.000817	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—KRAS—uterine cancer	3.42e-05	0.000813	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—KRAS—uterine cancer	3.33e-05	0.000793	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—uterine cancer	3.32e-05	0.000791	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—uterine cancer	3.32e-05	0.000791	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	3.32e-05	0.000789	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—NRAS—uterine cancer	3.29e-05	0.000783	CbGpPWpGaD
Ketotifen—PGD—Disease—HRAS—uterine cancer	3.23e-05	0.00077	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ESR1—uterine cancer	3.22e-05	0.000767	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCL2—uterine cancer	3.22e-05	0.000766	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CXCL8—uterine cancer	3.19e-05	0.000758	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—HRAS—uterine cancer	3.18e-05	0.000756	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—HRAS—uterine cancer	3.18e-05	0.000756	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PIK3CA—uterine cancer	3.14e-05	0.000747	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—KRAS—uterine cancer	3.1e-05	0.000737	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—ERBB2—uterine cancer	3.08e-05	0.000734	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCL2—uterine cancer	3.06e-05	0.000729	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PIK3CA—uterine cancer	3.06e-05	0.000729	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—NRAS—uterine cancer	3.04e-05	0.000725	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PIK3CA—uterine cancer	3.01e-05	0.000716	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—uterine cancer	2.97e-05	0.000708	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—uterine cancer	2.96e-05	0.000705	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PIK3CA—uterine cancer	2.93e-05	0.000697	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCL8—uterine cancer	2.92e-05	0.000696	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—HRAS—uterine cancer	2.9e-05	0.000691	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PIK3CA—uterine cancer	2.86e-05	0.000682	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1B—uterine cancer	2.85e-05	0.00068	CbGpPWpGaD
Ketotifen—PGD—Disease—AKT1—uterine cancer	2.85e-05	0.00068	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PIK3CA—uterine cancer	2.85e-05	0.000677	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCL2—uterine cancer	2.83e-05	0.000675	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—HRAS—uterine cancer	2.83e-05	0.000674	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—uterine cancer	2.83e-05	0.000674	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—AKT1—uterine cancer	2.82e-05	0.000672	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—AKT1—uterine cancer	2.81e-05	0.000668	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—AKT1—uterine cancer	2.81e-05	0.000668	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—uterine cancer	2.75e-05	0.000655	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PIK3CA—uterine cancer	2.73e-05	0.000651	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—uterine cancer	2.7e-05	0.000642	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ERBB2—uterine cancer	2.68e-05	0.000639	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKR1C3—uterine cancer	2.67e-05	0.000635	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—uterine cancer	2.65e-05	0.000631	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—HRAS—uterine cancer	2.63e-05	0.000627	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—uterine cancer	2.63e-05	0.000626	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—uterine cancer	2.62e-05	0.000624	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—uterine cancer	2.6e-05	0.000619	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PGR—uterine cancer	2.6e-05	0.000619	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—AKT1—uterine cancer	2.56e-05	0.00061	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ERBB2—uterine cancer	2.55e-05	0.000608	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL8—uterine cancer	2.54e-05	0.000606	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—HRAS—uterine cancer	2.53e-05	0.000602	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EP300—uterine cancer	2.51e-05	0.000597	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—AKT1—uterine cancer	2.5e-05	0.000595	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1B—uterine cancer	2.49e-05	0.000592	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—YWHAE—uterine cancer	2.48e-05	0.00059	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—AKT1—uterine cancer	2.46e-05	0.000585	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL8—uterine cancer	2.42e-05	0.000577	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—uterine cancer	2.41e-05	0.000573	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—HRAS—uterine cancer	2.41e-05	0.000573	CbGpPWpGaD
Ketotifen—PGD—Metabolism—AKT1—uterine cancer	2.39e-05	0.000569	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FBXW7—uterine cancer	2.38e-05	0.000566	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—uterine cancer	2.37e-05	0.000565	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1B—uterine cancer	2.37e-05	0.000563	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ERBB2—uterine cancer	2.36e-05	0.000563	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—uterine cancer	2.35e-05	0.000559	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—NRAS—uterine cancer	2.35e-05	0.000558	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—AKT1—uterine cancer	2.34e-05	0.000557	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—AKT1—uterine cancer	2.32e-05	0.000553	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—uterine cancer	2.29e-05	0.000545	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL8—uterine cancer	2.24e-05	0.000534	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—uterine cancer	2.23e-05	0.000532	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—AKT1—uterine cancer	2.23e-05	0.000531	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—HRAS—uterine cancer	2.23e-05	0.00053	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1B—uterine cancer	2.19e-05	0.000521	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EP300—uterine cancer	2.18e-05	0.00052	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—uterine cancer	2.18e-05	0.000519	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—AKT1—uterine cancer	2.16e-05	0.000515	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—AKT1—uterine cancer	2.12e-05	0.000506	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EP300—uterine cancer	2.08e-05	0.000494	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STK11—uterine cancer	2.08e-05	0.000494	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—uterine cancer	2.07e-05	0.000492	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCL2—uterine cancer	2.07e-05	0.000492	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—uterine cancer	2.07e-05	0.000492	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NRAS—uterine cancer	2.04e-05	0.000486	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—uterine cancer	2.02e-05	0.000481	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—uterine cancer	2.02e-05	0.00048	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—uterine cancer	1.97e-05	0.000468	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—AKT1—uterine cancer	1.97e-05	0.000468	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SOCS3—uterine cancer	1.94e-05	0.000463	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NRAS—uterine cancer	1.94e-05	0.000463	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EP300—uterine cancer	1.92e-05	0.000458	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN2B—uterine cancer	1.86e-05	0.000443	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—uterine cancer	1.85e-05	0.000441	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—uterine cancer	1.82e-05	0.000433	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1R—uterine cancer	1.81e-05	0.00043	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	1.8e-05	0.000429	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NRAS—uterine cancer	1.8e-05	0.000428	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—uterine cancer	1.79e-05	0.000427	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—uterine cancer	1.76e-05	0.000418	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HRAS—uterine cancer	1.72e-05	0.000408	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMAD3—uterine cancer	1.7e-05	0.000405	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—uterine cancer	1.67e-05	0.000398	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL8—uterine cancer	1.63e-05	0.000389	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGFR2—uterine cancer	1.62e-05	0.000386	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—uterine cancer	1.61e-05	0.000384	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—uterine cancer	1.56e-05	0.000372	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—uterine cancer	1.55e-05	0.000368	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—uterine cancer	1.54e-05	0.000366	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—AKT1—uterine cancer	1.51e-05	0.000361	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HRAS—uterine cancer	1.49e-05	0.000356	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—uterine cancer	1.49e-05	0.000354	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—uterine cancer	1.42e-05	0.000338	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HRAS—uterine cancer	1.42e-05	0.000338	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ESR1—uterine cancer	1.39e-05	0.00033	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—uterine cancer	1.38e-05	0.000327	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—AKT1—uterine cancer	1.32e-05	0.000314	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HRAS—uterine cancer	1.32e-05	0.000313	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—NRAS—uterine cancer	1.31e-05	0.000312	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—AKT1—uterine cancer	1.26e-05	0.000299	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCL2—uterine cancer	1.22e-05	0.000291	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—AKT1—uterine cancer	1.16e-05	0.000276	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	1.14e-05	0.000272	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—uterine cancer	1.13e-05	0.000269	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	1.04e-05	0.000247	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB2—uterine cancer	1.02e-05	0.000242	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL8—uterine cancer	9.66e-06	0.00023	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—HRAS—uterine cancer	9.59e-06	0.000228	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1B—uterine cancer	9.43e-06	0.000225	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT1—uterine cancer	9.33e-06	0.000222	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—uterine cancer	8.91e-06	0.000212	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—uterine cancer	8.68e-06	0.000207	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT1—uterine cancer	8.47e-06	0.000202	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EP300—uterine cancer	8.28e-06	0.000197	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—uterine cancer	7.84e-06	0.000187	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRAS—uterine cancer	7.75e-06	0.000184	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—uterine cancer	6.67e-06	0.000159	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—uterine cancer	6.13e-06	0.000146	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—uterine cancer	5.93e-06	0.000141	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HRAS—uterine cancer	5.67e-06	0.000135	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT1—uterine cancer	5e-06	0.000119	CbGpPWpGaD
